Recent Advances in Dual Disorders (Addiction and Other Mental Disorders)
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Mental Health".
Deadline for manuscript submissions: closed (10 October 2022) | Viewed by 27858
Special Issue Editors
2. Neuroscience Research Program-IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain
3. Addiction Program-Hospital del Mar, 08003 Barcelona, Spain
Interests: substance use disorders; dual disorders; gender perspective; new psychoactive substances
Special Issues, Collections and Topics in MDPI journals
2. Institute of Neurosciences, University of Barcelona, 08035 Barcelona, Spain
Interests: substance use; dual disorders; chronobiology; circadian rhythms; neurocognition; severe mental illness
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
In September 2019, our Special Issue “Diagnosis and Management of Addiction and Other Mental Disorders (Dual Disorders)” was launched (https://www.mdpi.com/journal/jcm/special_issues/Addiction_Dual_Disorders). A number of papers on different topics, from basic to clinical perspectives, were published with a very positive impact on scientists and professionals on the subject.
The individual, social, and public health impact of dual disorders (the co-occurrence of drug use disorders with other mental health conditions) is extremely high, and a multidisciplinary and comprehensive response to the needs of persons with these disorders is required. Unfortunately, there are many gaps in the global system, which is ill-prepared to meet this challenge. The percentage of patients suffering from dual disorders is high, and in recent years, the epidemiological data have been steadily increasing. This is occurring in parallel with evidence of greater difficulties in both clinical management and stabilization of these patients compared to those with only one disorder (e.g., increases admissions in emergency rooms, hospitalizations, suicide).
The COVID-19 pandemic has already had a negative impact on mental health, especially in the young population, thus leading to the detection of both substance and behavioral addictions and many other mental disorders (major depression, anxiety, eating disorders, etc.). All of this is taking place in health systems that are already traditionally under pressure in the field of mental health, regardless of the country and model of care, and where there is a need for specialized centers and professionals trained in the management of dual disorders. This situation will only be overcome with rigorous work from multiple approaches (biological, psychological, social) that allows for interdisciplinary integration that will lead to future advances in knowledge and to overcoming of the deficits that exist today and new opportunities to improve them.
Given the success of our first Special Issue, we believe that it is time to launch a second Special Issue aimed at compiling recent advances in dual disorders, considering different levels of approach that provide interesting data with a view to being transferred as soon as possible to healthcare. In this sense, consensus papers, expert reviews and study protocols are also welcome. Methodologically sound research with valid and reliable procedures is a prerequisite for acceptance.
We welcome both solicited and unsolicited submissions that will contribute to this goal.
Prof. Dr. Marta Torrens
Prof. Dr. Ana Adan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Dual disorders
- Substance use disorders
- Addictive disorders
- Psychiatric comorbidity
- Risk factors
- Clinical predictors
- Endophenotypes
- Treatment
- COVID-19 impact
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.